List of Tables
Table 1. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Competitive Situation by Manufacturers in 2023
Table 4. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Product Type & Application
Table 12. Global Key Manufacturers of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2019-2024) & (K Dose)
Table 18. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Region (2019-2024)
Table 19. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2025-2030) & (K Dose)
Table 20. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Region (2025-2030)
Table 21. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Region (2019-2024)
Table 23. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Region (2025-2030)
Table 25. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2024) & (K Dose)
Table 27. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2025-2030) & (K Dose)
Table 28. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2024) & (K Dose)
Table 32. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2025-2030) & (K Dose)
Table 33. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose) by Type (2019-2024)
Table 51. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose) by Type (2025-2030)
Table 52. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Type (2019-2024)
Table 53. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Type (2025-2030)
Table 54. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Type (2019-2024)
Table 57. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Type (2025-2030)
Table 58. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price (US$/Dose) by Type (2019-2024)
Table 59. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price (US$/Dose) by Type (2025-2030)
Table 60. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose) by Application (2019-2024)
Table 61. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose) by Application (2025-2030)
Table 62. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Application (2019-2024)
Table 63. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Application (2025-2030)
Table 64. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Application (2019-2024)
Table 67. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Application (2025-2030)
Table 68. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price (US$/Dose) by Application (2019-2024)
Table 69. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price (US$/Dose) by Application (2025-2030)
Table 70. Zoetis Company Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Zoetis FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Boehringer Ingelheim Company Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Boehringer Ingelheim FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Merck FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product
Table 84. Merck Recent Developments/Updates
Table 85. Tianjin Rinpu Company Information
Table 86. Tianjin Rinpu Description and Business Overview
Table 87. Tianjin Rinpu FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Tianjin Rinpu FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Product
Table 89. Tianjin Rinpu Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Distributors List
Table 93. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Customers List
Table 94. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Trends
Table 95. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Drivers
Table 96. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Challenges
Table 97. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine)
Figure 2. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Share by Type: 2023 & 2030
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Inactivated Vaccine Product Picture
Figure 6. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Share by Application: 2023 & 2030
Figure 8. 8 Weeks and Older
Figure 9. 12 Weeks and Older
Figure 10. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size (2019-2030) & (US$ Million)
Figure 12. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales (2019-2030) & (K Dose)
Figure 13. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Average Price (US$/Dose) & (2019-2030)
Figure 14. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Report Years Considered
Figure 15. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Share by Manufacturers in 2023
Figure 16. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Share by Manufacturers in 2023
Figure 17. Global 5 and 10 Largest FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Players: Market Share by Revenue in FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) in 2023
Figure 18. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Country (2019-2030)
Figure 21. North America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Country (2019-2030)
Figure 22. United States FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Country (2019-2030)
Figure 25. Europe FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Country (2019-2030)
Figure 26. Germany FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Region (2019-2030)
Figure 33. China FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Country (2019-2030)
Figure 41. Mexico FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Brazil FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Argentina FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Colombia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Sales Market Share by Country (2019-2030)
Figure 46. Middle East and Africa FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Market Share by Country (2019-2030)
Figure 47. Turkey FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) by Type (2019-2030)
Figure 51. Global Revenue Market Share of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) by Type (2019-2030)
Figure 52. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price (US$/Dose) by Type (2019-2030)
Figure 53. Global Sales Market Share of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) by Application (2019-2030)
Figure 54. Global Revenue Market Share of FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) by Application (2019-2030)
Figure 55. Global FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Price (US$/Dose) by Application (2019-2030)
Figure 56. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Value Chain
Figure 57. FVRCP (Feline Viral Rhinotracheitis-Calici-Panleukopenia Vaccine) Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed